pharmaceutical investing Eloxx Pharmaceuticals Announces Uplisting to Nasdaq and Pricing of $50 Million Public Offering of Common Stock
SAGA Metals Reports Assays from R-0058 to R-0060 with Intercepts Including 43.86% Fe2O3, 6.10% TiO2, 0.317% V2O5 from 2026 Drilling at Radar Critical Minerals Project in Labrador and Adds to Its Advisory Board
